<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35490693</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2214-109X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Lancet. Global health</Title>
          <ISOAbbreviation>Lancet Glob Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden.</ArticleTitle>
        <Pagination>
          <StartPage>e807</StartPage>
          <EndPage>e819</EndPage>
          <MedlinePgn>e807-e819</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/S2214-109X(22)00093-6</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S2214-109X(22)00093-6</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Group B streptococcus (GBS) colonisation during pregnancy can lead to invasive GBS disease (iGBS) in infants, including meningitis or sepsis, with a high mortality risk. Other outcomes include stillbirths, maternal infections, and prematurity. There are data gaps, notably regarding neurodevelopmental impairment (NDI), especially after iGBS sepsis, which have limited previous global estimates. In this study, we aimed to address this gap using newly available multicountry datasets.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We collated and meta-analysed summary data, primarily identified in a series of systematic reviews published in 2017 but also from recent studies on NDI and stillbirths, using Bayesian hierarchical models, and estimated the burden for 183 countries in 2020 regarding: maternal GBS colonisation, iGBS cases and deaths in infants younger than 3 months, children surviving iGBS affected by NDI, and maternal iGBS cases. We analysed the proportion of stillbirths with GBS and applied this to the UN-estimated stillbirth risk per country. Excess preterm births associated with maternal GBS colonisation were calculated using meta-analysis and national preterm birth rates.</AbstractText>
          <AbstractText Label="FINDINGS" NlmCategory="RESULTS">Data from the seven systematic reviews, published in 2017, that informed the previous burden estimation (a total of 515 data points) were combined with new data (17 data points) from large multicountry studies on neurodevelopmental impairment (two studies) and stillbirths (one study). A posterior median of 19·7 million (95% posterior interval 17·9-21·9) pregnant women were estimated to have rectovaginal colonisation with GBS in 2020. 231 800 (114 100-455 000) early-onset and 162 200 (70 200-394 400) late-onset infant iGBS cases were estimated to have occurred. In an analysis assuming a higher case fatality rate in the absence of a skilled birth attendant, 91 900 (44 800-187 800) iGBS infant deaths were estimated; in an analysis without this assumption, 58 300 (26 500-125 800) infant deaths from iGBS were estimated. 37 100 children who recovered from iGBS (14 600-96 200) were predicted to develop moderate or severe NDI. 40 500 (21 500-66 200) maternal iGBS cases and 46 200 (20 300-111 300) GBS stillbirths were predicted in 2020. GBS colonisation was also estimated to be potentially associated with considerable numbers of preterm births.</AbstractText>
          <AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Our analysis provides a comprehensive assessment of the pregnancy-related GBS burden. The Bayesian approach enabled coherent propagation of uncertainty, which is considerable, notably regarding GBS-associated preterm births. Our findings on both the acute and long-term consequences of iGBS have public health implications for understanding the value of investment in maternal GBS immunisation and other preventive strategies.</AbstractText>
          <AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Bill &amp; Melinda Gates Foundation.</AbstractText>
          <CopyrightInformation>Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gonçalves</LastName>
            <ForeName>Bronner P</ForeName>
            <Initials>BP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK; Maternal, Adolescent, Reproductive &amp; Child Health Centre, London School of Hygiene &amp; Tropical Medicine, London, UK. Electronic address: bronner.goncalves@lshtm.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Procter</LastName>
            <ForeName>Simon R</ForeName>
            <Initials>SR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK; Maternal, Adolescent, Reproductive &amp; Child Health Centre, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paul</LastName>
            <ForeName>Proma</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK; Maternal, Adolescent, Reproductive &amp; Child Health Centre, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chandna</LastName>
            <ForeName>Jaya</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK; Maternal, Adolescent, Reproductive &amp; Child Health Centre, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lewin</LastName>
            <ForeName>Alexandra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Statistics, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Seedat</LastName>
            <ForeName>Farah</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK; Maternal, Adolescent, Reproductive &amp; Child Health Centre, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Koukounari</LastName>
            <ForeName>Artemis</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK; Maternal, Adolescent, Reproductive &amp; Child Health Centre, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dangor</LastName>
            <ForeName>Ziyaad</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council, Vaccines and Infectious Diseases Analytical Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leahy</LastName>
            <ForeName>Shannon</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santhanam</LastName>
            <ForeName>Sridhar</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Neonatology Department, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>John</LastName>
            <ForeName>Hima B</ForeName>
            <Initials>HB</Initials>
            <AffiliationInfo>
              <Affiliation>Neonatology Department, Christian Medical College, Vellore, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bramugy</LastName>
            <ForeName>Justina</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bardají</LastName>
            <ForeName>Azucena</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abubakar</LastName>
            <ForeName>Amina</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Group, Department of Clinical Sciences, Kenyan Medical Research Institute, Wellcome Trust, Kilifi, Kenya; Institute for Human Development, Aga Khan University, Nairobi, Kenya.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nasambu</LastName>
            <ForeName>Carophine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Neuroscience Research Group, Department of Clinical Sciences, Kenyan Medical Research Institute, Wellcome Trust, Kilifi, Kenya.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Libster</LastName>
            <ForeName>Romina</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Fundación INFANT, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sánchez Yanotti</LastName>
            <ForeName>Clara</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Fundación INFANT, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Horváth-Puhó</LastName>
            <ForeName>Erzsébet</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sørensen</LastName>
            <ForeName>Henrik T</ForeName>
            <Initials>HT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van de Beek</LastName>
            <ForeName>Diederik</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bijlsma</LastName>
            <ForeName>Merijn W</ForeName>
            <Initials>MW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Department of Paediatrics, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gardner</LastName>
            <ForeName>William M</ForeName>
            <Initials>WM</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kassebaum</LastName>
            <ForeName>Nicholas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Departments of Global Health and Health Metrics Sciences, University of Washington, Seattle, WA, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Trotter</LastName>
            <ForeName>Caroline</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Disease Dynamics Unit, Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bassat</LastName>
            <ForeName>Quique</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Catalan Institution for Research and Advanced Studies, Barcelona, Spain; Pediatrics Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Madhi</LastName>
            <ForeName>Shabir A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>South African Medical Research Council, Vaccines and Infectious Diseases Analytical Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology and National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lambach</LastName>
            <ForeName>Philipp</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jit</LastName>
            <ForeName>Mark</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lawn</LastName>
            <ForeName>Joy E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London, UK; Maternal, Adolescent, Reproductive &amp; Child Health Centre, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>GBS Danish and Dutch collaborative group for long term outcomes</CollectiveName>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>GBS Low and Middle Income Countries collaborative group for long term outcomes</CollectiveName>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>GBS Scientific Advisory Group, epidemiological sub-group</CollectiveName>
          </Author>
          <Author ValidYN="Y">
            <CollectiveName>CHAMPS team</CollectiveName>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D017418">Meta-Analysis</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Lancet Glob Health</MedlineTA>
        <NlmUniqueID>101613665</NlmUniqueID>
        <ISSNLinking>2214-109X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>Lancet Glob Health. 2022 May 12;:</RefSource>
          <PMID Version="1">35569488</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D066088" MajorTopicYN="N">Infant Death</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047928" MajorTopicYN="Y">Premature Birth</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050497" MajorTopicYN="N">Stillbirth</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013290" MajorTopicYN="Y">Streptococcal Infections</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013292" MajorTopicYN="N">Streptococcus agalactiae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000078202" MajorTopicYN="N">Systematic Reviews as Topic</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>Declaration of interests The Department of Clinical Epidemiology of Aarhus University receives funding from private and public institutions in the form of institutional research grants to (and administered by) Aarhus University; none of these grants has any relation to the present study. SAM declares funding from Astrazeneca, the Bill &amp; Melinda Gates Foundation, GlaxoSmithKline, Minervax, Novavax, Pfizer, and the South Africa Medical Research Council; in particular, SAM delares funding to his institution from Pfizer for epidemiology studies on group B streptococcus (GBS) and a clinical trial on the GBS vaccine, and from the Bill &amp; Melinda Gates Foundation on GBS epidemiology. FS declares employment by the UK National Screening Committee, which developed the policy recommendation for maternal GBS screening. CT declares a consulting fee from WHO for drafting a report on the Full Value of Vaccine Assessment for GBS vaccines, which is related to the current manuscript. RL declares participation on an advisory board for Janssen and Pfizer; payment for lectures from Reckitt; and grants to Fundación INFANT from the Bill &amp; Melinda Gates Foundation and PATH. All other authors declare no competing interests.</CoiStatement>
      <InvestigatorList>
        <Investigator ValidYN="Y">
          <LastName>Søgaard</LastName>
          <ForeName>Kirstine K</ForeName>
          <Initials>KK</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van Kassel</LastName>
          <ForeName>Merel N</ForeName>
          <Initials>MN</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Snoek</LastName>
          <ForeName>Linde</ForeName>
          <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>de Gier</LastName>
          <ForeName>Brechje</ForeName>
          <Initials>B</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>van der Ende</LastName>
          <ForeName>Arie</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hahné</LastName>
          <ForeName>Susan J M</ForeName>
          <Initials>SJM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Harden</LastName>
          <ForeName>Lois M</ForeName>
          <Initials>LM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ghoor</LastName>
          <ForeName>Azra</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mbatha</LastName>
          <ForeName>Sibongile</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lowick</LastName>
          <ForeName>Sarah</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Laughton</LastName>
          <ForeName>Barbara</ForeName>
          <Initials>B</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Jaye</LastName>
          <ForeName>Tamara</ForeName>
          <Initials>T</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Lala</LastName>
          <ForeName>Sanjay G</ForeName>
          <Initials>SG</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Sithole</LastName>
          <ForeName>Pamela</ForeName>
          <Initials>P</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Msayi</LastName>
          <ForeName>Jacqueline</ForeName>
          <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kumalo</LastName>
          <ForeName>Ntombifuthi</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Msibi</LastName>
          <ForeName>Tshepiso Nompumelelo</ForeName>
          <Initials>TN</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Arumugam</LastName>
          <ForeName>Asha</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Murugesan</LastName>
          <ForeName>Nandhini</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rajendraprasad</LastName>
          <ForeName>Nandhini</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Priya</LastName>
          <ForeName>Mohana</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mabrouk</LastName>
          <ForeName>Adam</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Katana</LastName>
          <ForeName>Patrick Vidzo</ForeName>
          <Initials>PV</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mwangome</LastName>
          <ForeName>Eva</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Newton</LastName>
          <ForeName>Charles R</ForeName>
          <Initials>CR</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mucasse</LastName>
          <ForeName>Humberto</ForeName>
          <Initials>H</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Aerts</LastName>
          <ForeName>Celine</ForeName>
          <Initials>C</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Massora</LastName>
          <ForeName>Sergio</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Medina</LastName>
          <ForeName>Valeria</ForeName>
          <Initials>V</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rojas</LastName>
          <ForeName>Andrea</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Amado</LastName>
          <ForeName>Daniel</ForeName>
          <Initials>D</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Llapur</LastName>
          <ForeName>Conrado J</ForeName>
          <Initials>CJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Hossain</LastName>
          <ForeName>A K M Tanvir</ForeName>
          <Initials>AKMT</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Rahman</LastName>
          <ForeName>Qazi Sadeq-Ur</ForeName>
          <Initials>QS</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ip</LastName>
          <ForeName>Margaret</ForeName>
          <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Seale</LastName>
          <ForeName>Anna</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Heath</LastName>
          <ForeName>Paul T</ForeName>
          <Initials>PT</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Le Doare</LastName>
          <ForeName>Kirsty</ForeName>
          <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Khalil</LastName>
          <ForeName>Asma</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Schrag</LastName>
          <ForeName>Stephanie J</ForeName>
          <Initials>SJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Sobanjo-Ter Meulen</LastName>
          <ForeName>Ajoke</ForeName>
          <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mason</LastName>
          <ForeName>Elizabeth</ForeName>
          <Initials>E</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Blau</LastName>
          <ForeName>Dianna M</ForeName>
          <Initials>DM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>El Arifeen</LastName>
          <ForeName>Shams</ForeName>
          <Initials>S</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Assefa</LastName>
          <ForeName>Nega</ForeName>
          <Initials>N</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Onyango</LastName>
          <ForeName>Dickens</ForeName>
          <Initials>D</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Sow</LastName>
          <ForeName>Samba O</ForeName>
          <Initials>SO</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mandomando</LastName>
          <ForeName>Inacio</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Ogbuanu</LastName>
          <ForeName>Ikechukwu</ForeName>
          <Initials>I</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Kotloff</LastName>
          <ForeName>Karen L</ForeName>
          <Initials>KL</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Scott</LastName>
          <ForeName>J Anthony G</ForeName>
          <Initials>JAG</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Gurley</LastName>
          <ForeName>Emily S</ForeName>
          <Initials>ES</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Barr</LastName>
          <ForeName>Beth A Tippet</ForeName>
          <Initials>BAT</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
          <LastName>Mahtab</LastName>
          <ForeName>Sana</ForeName>
          <Initials>S</Initials>
        </Investigator>
      </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>1</Day>
          <Hour>18</Hour>
          <Minute>57</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35490693</ArticleId>
        <ArticleId IdType="doi">10.1016/S2214-109X(22)00093-6</ArticleId>
        <ArticleId IdType="pii">S2214-109X(22)00093-6</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
